DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California

Ads

You May Also Like

Versartis Reports Fourth Quarter 2016 Financial Results

MENLO PARK, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...

Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

DUBLIN, IRELAND, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results

VANCOUVER, British Columbia, May 09, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...